Research


TRC Networks and Systemic Risk

with Roger Stein, Journal of Alternative Investment 18(2016), 52–67.

View abstract

Health, Wealth, and the 21st Century Cures Act

with Tomas Philipson and Andrew von Eschenbach, JAMA Oncology 2(2016), 17–18.

View abstract

Price, Value, and the Cost of Cancer Drugs

with Tito Fojo  , Lancet Oncology 17(2016), 3–5.

View abstract

Business Models to Cure Rare Disease: A Case Study of Solid Biosciences

with Esther Kim, Journal of Investment Management 14(2016), 87–101.

View abstract

Q Group Panel Discussion: Looking to the Future

with Martin Leibowitz, Robert C. Merton, Stephen A. Ross, and Jeremy Siegel, Financial Analysts Journal

View abstract

Imagine if Robo Advisers Could Do Emotions

Wall Street Journal

View abstract

Spectral Portfolio Theory

View abstract

‘Health care loans’ for Hep C cure

with David Weinstock, The Boston Globe

View abstract

Buying Cures Versus Renting Health: Financing Health Care with Consumer Loans

with Vahid Montazerhodjat and David M. Weinstock, Science Translational Medicine 8(2016), 327ps6.

View abstract

Financing Drug Discovery via Dynamic Leverage

with Vahid Montazerhodjat and John J. Frishkopf, Drug Discovery Today 21(2016), 410–414.

View abstract

Follow me on © 2017 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design